| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Mechanisms of Tumor Promotion Section, Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland 20205
We examined the ability of a series of highly lipophilic phorbol esters to inhibit [20-3H]phorbol 12,13-dibutyrate binding to the cytosolic aporeceptor from mouse brain. If added in the usual fashion directly into the aqueous phase of the assay mixture, phorbol 12,13-distearate, phorbol 12,13-dioleate, and phorbol 12,13-dimyristate showed very weak inhibitory activities, with apparent inhibitor equilibrium dissociation constant values above 4 µM. In contrast, if incorporated directly into the liposomes used to reconstitute the aporeceptor, all three derivatives inhibited binding with high apparent affinities, 7.4 to 34 nM. The less lipophilic derivative phorbol 12,13-didecanoate showed a similar high affinity, 2.4 to 3.2 nM, by either route of addition. Consistent with the activity of the lipophilic derivatives being masked by an inability to transfer from the aqueous to the lipid phase, phorbol 12,13-distearate added to the aqueous phase inhibited efficiently (apparent inhibitor equilibrium dissociation constant, 14 nM) in the presence of 0.03% Triton X-100. The results suggest that the phorbol ester receptor recognizes phorbol esters which are inserted into the lipid bilayer. They indicate, moreover, that the apparent low activity of the more lipophilic phorbol esters is strongly influenced by factors other than equilibrium binding affinities.
1 To whom requests for reprints should be addressed.
Received 4/ 2/84. Accepted 10/ 9/84.
This article has been cited by other articles:
|
|
 |
|
  D. C. Braun, Y. Cao, S. Wang, S. H. Garfield, G. Min Hur, and P. M. Blumberg Role of phorbol ester localization in determining protein kinase C or RasGRP3 translocation: Real-time analysis using fluorescent ligands and proteins Mol. Cancer Ther., January 1, 2005; 4(1): 141 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Madani, A. Hichami, M. Charkaoui-Malki, and N. A. Khan Diacylglycerols Containing Omega 3 and Omega 6 Fatty Acids Bind to RasGRP and Modulate MAP Kinase Activation J. Biol. Chem., January 9, 2004; 279(2): 1176 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shindo, K. Irie, A. Masuda, H. Ohigashi, Y. Shirai, K. Miyasaka, and N. Saito Synthesis and Phorbol Ester Binding of the Cysteine-rich Domains of Diacylglycerol Kinase (DGK) Isozymes. DGKgamma AND DGKbeta ARE NEW TARGETS OF TUMOR-PROMOTING PHORBOL ESTERS J. Biol. Chem., May 9, 2003; 278(20): 18448 - 18454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Imai, F. Sakane, and H. Kanoh Phorbol Ester-regulated Oligomerization of Diacylglycerol Kinase delta Linked to Its Phosphorylation and Translocation J. Biol. Chem., September 13, 2002; 277(38): 35323 - 35332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Roaten, M. G. Kazanietz, M. J. Caloca, P. J. Bertics, L. Lothstein, A. L. Parrill, M. Israel, and T. W. Sweatman Interaction of the Novel Anthracycline Antitumor Agent N-Benzyladriamycin-14-valerate with the C1-Regulatory Domain of Protein Kinase C: Structural Requirements, Isoform Specificity, and Correlation with Drug Cytotoxicity Mol. Cancer Ther., May 1, 2002; 1(7): 483 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Lorenzo, J. W. Kung, D. A. Bottorff, S. H. Garfield, J. C. Stone, and P. M. Blumberg Phorbol Esters Modulate the Ras Exchange Factor RasGRP3 Cancer Res., February 1, 2001; 61(3): 943 - 949. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. S. Lorenzo, M. Beheshti, G. R. Pettit, J. C. Stone, and P. M. Blumberg The Guanine Nucleotide Exchange Factor RasGRP Is a High -Affinity Target for Diacylglycerol and Phorbol Esters Mol. Pharmacol., May 1, 2000; 57(5): 840 - 846. [Abstract] [Full Text]
|
|
|
|
|
|
Q. J. Wang, T.-W. Fang, D. Fenick, S. Garfield, B. Bienfait, V. E. Marquez, and P. M. Blumberg The Lipophilicity of Phorbol Esters as a Critical Factor in Determining the Pattern of Translocation of Protein Kinase C delta Fused to Green Fluorescent Protein J. Biol. Chem., April 14, 2000; 275(16): 12136 - 12146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fujii, M. L. Garcia-Bermejo, J. L. Bernabo, J. Caamano, M. Ohba, T. Kuroki, L. Li, S. H. Yuspa, and M. G. Kazanietz Involvement of Protein Kinase C delta (PKCdelta ) in Phorbol Ester-induced Apoptosis in LNCaP Prostate Cancer Cells. LACK OF PROTEOLYTIC CLEAVAGE OF PKCdelta J. Biol. Chem., March 10, 2000; 275(11): 7574 - 7582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Lorenzo, K. Bogi, K. M. Hughes, M. Beheshti, D. Bhattacharyya, S. H. Garfield, G. R. Pettit, and P. M. Blumberg Differential Roles of the Tandem C1 Domains of Protein Kinase C {{delta}} in the Biphasic Down-Regulation Induced by Bryostatin 1 Cancer Res., December 1, 1999; 59(24): 6137 - 6144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Caloca, M. L. Garcia-Bermejo, P. M. Blumberg, N. E. Lewin, E. Kremmer, H. Mischak, S. Wang, K. Nacro, B. Bienfait, V. E. Marquez, et al. beta 2-Chimaerin is a novel target for diacylglycerol: Binding properties and changes in subcellular localization mediated by ligand binding to its C1 domain PNAS, October 12, 1999; 96(21): 11854 - 11859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Prekeris, R. M. Hernandez, M. W. Mayhew, M. K. White, and D. M. Terrian Molecular Analysis of the Interactions between Protein Kinase C-epsilon and Filamentous Actin J. Biol. Chem., October 9, 1998; 273(41): 26790 - 26798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Caloca, N. Fernandez, N. E. Lewin, D. Ching, R. Modali, P. M. Blumberg, and M. G. Kazanietz beta 2-Chimaerin Is a High Affinity Receptor for the Phorbol Ester Tumor Promoters J. Biol. Chem., October 17, 1997; 272(42): 26488 - 26496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. J. Wang, P. Acs, J. Goodnight, T. Giese, P. M. Blumberg, H. Mischak, and J. F. Mushinski The Catalytic Domain of Protein Kinase C-delta in Reciprocal delta and epsilon Chimeras Mediates Phorbol Ester-induced Macrophage Differentiation of Mouse Promyelocytes J. Biol. Chem., January 3, 1997; 272(1): 76 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Kazanietz, S. Wang, G. W. A. Milne, N. E. Lewin, H. L. Liu, and P. M. Blumberg Residues in the Second Cysteine-rich Region of Protein Kinase C [IMAGE] Relevant to Phorbol Ester Binding as Revealed by Site-directed Mutagenesis J. Biol. Chem., September 15, 1995; 270(37): 21852 - 21859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Kazanietz, J. J. Barchi Jr., J. G. Omichinski, and P. M. Blumberg Low Affinity Binding of Phorbol Esters to Protein Kinase C and Its Recombinant Cysteine-rich Region in the Absence of Phospholipids J. Biol. Chem., June 16, 1995; 270(24): 14679 - 14684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Kazanietz, N. E. Lewin, J. D. Bruns, and P. M. Blumberg Characterization of the Cysteine-rich Region of the Caenorhabditiselegans Protein Unc-13 as a High Affinity Phorbol Ester Receptor J. Biol. Chem., May 5, 1995; 270(18): 10777 - 10783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. J. Wang, T.-W. Fang, K. Nacro, V. E. Marquez, S. Wang, and P. M. Blumberg Role of Hydrophobic Residues in the C1b Domain of Protein Kinase C delta on Ligand and Phospholipid Interactions J. Biol. Chem., May 25, 2001; 276(22): 19580 - 19587. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
